An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Animal Vaccine Adjuvant market is projected to reach US$ 496.5 million in 2029, increasing from US$ 330 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Animal Vaccine Adjuvant market research.
Globally, dog and cat ownership is gaining popularity, especially after the pandemic. Such an increase in the rate of pet ownership across the world is expected to boost the market's growth. The increasing animal health expenditure by owners to ensure better diagnosis and treatment and increasing pet ownership are expected to positively impact the veterinary vaccine adjuvants market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Animal Vaccine Adjuvant market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Croda
SEPPIC
SDA BIO
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
Segment by Type
Oral
Subcutaneous
Intramuscular
Others
Segment by Application
Livestock Vaccines
Companion Animals Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Animal Vaccine Adjuvant report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Animal Vaccine Adjuvant 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intramuscular
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Animal Vaccine Adjuvant 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Livestock Vaccines
1.3.3 Companion Animals Vaccines
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Vaccine Adjuvant 麻豆原创 Perspective (2018-2029)
2.2 Animal Vaccine Adjuvant Growth Trends by Region
2.2.1 Global Animal Vaccine Adjuvant 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Animal Vaccine Adjuvant Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Animal Vaccine Adjuvant Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Animal Vaccine Adjuvant 麻豆原创 Dynamics
2.3.1 Animal Vaccine Adjuvant Industry Trends
2.3.2 Animal Vaccine Adjuvant 麻豆原创 Drivers
2.3.3 Animal Vaccine Adjuvant 麻豆原创 Challenges
2.3.4 Animal Vaccine Adjuvant 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Vaccine Adjuvant Players by Revenue
3.1.1 Global Top Animal Vaccine Adjuvant Players by Revenue (2018-2023)
3.1.2 Global Animal Vaccine Adjuvant Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Animal Vaccine Adjuvant 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Vaccine Adjuvant Revenue
3.4 Global Animal Vaccine Adjuvant 麻豆原创 Concentration Ratio
3.4.1 Global Animal Vaccine Adjuvant 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Vaccine Adjuvant Revenue in 2022
3.5 Animal Vaccine Adjuvant Key Players Head office and Area Served
3.6 Key Players Animal Vaccine Adjuvant Product Solution and Service
3.7 Date of Enter into Animal Vaccine Adjuvant 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Vaccine Adjuvant Breakdown Data by Type
4.1 Global Animal Vaccine Adjuvant Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Animal Vaccine Adjuvant Forecasted 麻豆原创 Size by Type (2024-2029)
5 Animal Vaccine Adjuvant Breakdown Data by Application
5.1 Global Animal Vaccine Adjuvant Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Animal Vaccine Adjuvant Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Animal Vaccine Adjuvant 麻豆原创 Size (2018-2029)
6.2 North America Animal Vaccine Adjuvant 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Animal Vaccine Adjuvant 麻豆原创 Size by Country (2018-2023)
6.4 North America Animal Vaccine Adjuvant 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Vaccine Adjuvant 麻豆原创 Size (2018-2029)
7.2 Europe Animal Vaccine Adjuvant 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Animal Vaccine Adjuvant 麻豆原创 Size by Country (2018-2023)
7.4 Europe Animal Vaccine Adjuvant 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Vaccine Adjuvant 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Animal Vaccine Adjuvant 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Animal Vaccine Adjuvant 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Animal Vaccine Adjuvant 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Vaccine Adjuvant 麻豆原创 Size (2018-2029)
9.2 Latin America Animal Vaccine Adjuvant 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Animal Vaccine Adjuvant 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Animal Vaccine Adjuvant 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Vaccine Adjuvant 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Animal Vaccine Adjuvant 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Animal Vaccine Adjuvant 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Animal Vaccine Adjuvant 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Croda
11.1.1 Croda Company Detail
11.1.2 Croda Business Overview
11.1.3 Croda Animal Vaccine Adjuvant Introduction
11.1.4 Croda Revenue in Animal Vaccine Adjuvant Business (2018-2023)
11.1.5 Croda Recent Development
11.2 SEPPIC
11.2.1 SEPPIC Company Detail
11.2.2 SEPPIC Business Overview
11.2.3 SEPPIC Animal Vaccine Adjuvant Introduction
11.2.4 SEPPIC Revenue in Animal Vaccine Adjuvant Business (2018-2023)
11.2.5 SEPPIC Recent Development
11.3 SDA BIO
11.3.1 SDA BIO Company Detail
11.3.2 SDA BIO Business Overview
11.3.3 SDA BIO Animal Vaccine Adjuvant Introduction
11.3.4 SDA BIO Revenue in Animal Vaccine Adjuvant Business (2018-2023)
11.3.5 SDA BIO Recent Development
11.4 SPI Pharma
11.4.1 SPI Pharma Company Detail
11.4.2 SPI Pharma Business Overview
11.4.3 SPI Pharma Animal Vaccine Adjuvant Introduction
11.4.4 SPI Pharma Revenue in Animal Vaccine Adjuvant Business (2018-2023)
11.4.5 SPI Pharma Recent Development
11.5 MVP Laboratories
11.5.1 MVP Laboratories Company Detail
11.5.2 MVP Laboratories Business Overview
11.5.3 MVP Laboratories Animal Vaccine Adjuvant Introduction
11.5.4 MVP Laboratories Revenue in Animal Vaccine Adjuvant Business (2018-2023)
11.5.5 MVP Laboratories Recent Development
11.6 Zhuoyue
11.6.1 Zhuoyue Company Detail
11.6.2 Zhuoyue Business Overview
11.6.3 Zhuoyue Animal Vaccine Adjuvant Introduction
11.6.4 Zhuoyue Revenue in Animal Vaccine Adjuvant Business (2018-2023)
11.6.5 Zhuoyue Recent Development
11.7 Zhiju Bio
11.7.1 Zhiju Bio Company Detail
11.7.2 Zhiju Bio Business Overview
11.7.3 Zhiju Bio Animal Vaccine Adjuvant Introduction
11.7.4 Zhiju Bio Revenue in Animal Vaccine Adjuvant Business (2018-2023)
11.7.5 Zhiju Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Croda
SEPPIC
SDA BIO
SPI Pharma
MVP Laboratories
Zhuoyue
Zhiju Bio
听
听
*If Applicable.
